EYLEA for Choroidal neovascularisation: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where EYLEA was used for Choroidal neovascularisation.
Most Reported Side Effects for EYLEA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 195 | 48.0% | 190 | 0 |
| Visual acuity reduced | 31 | 7.6% | 0 | 5 |
| Retinal haemorrhage | 25 | 6.2% | 0 | 4 |
| Blindness | 20 | 4.9% | 0 | 1 |
| Eye pain | 15 | 3.7% | 0 | 3 |
| Blindness transient | 13 | 3.2% | 0 | 2 |
| Endophthalmitis | 13 | 3.2% | 0 | 3 |
| Inappropriate schedule of drug administration | 13 | 3.2% | 0 | 4 |
| Vision blurred | 12 | 3.0% | 0 | 1 |
| Drug ineffective | 11 | 2.7% | 0 | 1 |
| Uveitis | 11 | 2.7% | 0 | 0 |
| Visual impairment | 11 | 2.7% | 0 | 1 |
| Ocular hyperaemia | 8 | 2.0% | 0 | 2 |
| Vitreous haemorrhage | 8 | 2.0% | 0 | 1 |
| Blood pressure increased | 7 | 1.7% | 2 | 3 |
Other Indications for EYLEA
Age-related macular degeneration (156)
Product used for unknown indication (22)
Retinal vein occlusion (7)
Macular degeneration (6)
Other Drugs Used for Choroidal neovascularisation
AFLIBERCEPT (2,953)
RANIBIZUMAB (1,364)
FARICIMAB\FARICIMAB-SVOA (306)
BEVACIZUMAB (302)
BROLUCIZUMAB-DBLL (104)
BROLUCIZUMAB (102)
FARICIMAB-SVOA (65)
VERTEPORFIN (42)
AVASTIN (12)
LUCENTIS (11)